|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Datta J, Islam M, Dutta S, Roy S, Pan Q
and Teknos TN: Suberoylanilide hydroxamic acid inhibits growth of
head and neck cancer cell lines by reactivation of tumor suppressor
microRNAs. Oral Oncol. 56:32–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Zheng L, Zhang F, Hu J, Chou J, Liu
Y, Xing Y and Xi T: STARD13-correlated ceRNA network inhibits EMT
and metastasis of breast cancer. Oncotarget. 7:23197–23211.
2016.PubMed/NCBI
|
|
4
|
Zheng L, Li X, Gu Y, Lv X and Xi T: The
3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in
breast cancer by acting as a ceRNA for CYP4Z1. Breast Cancer Res
Treat. 150:105–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ye ZN, Liu JP, Wu LY, Zhang XS, Zhuang Z,
Chen Q, Lu Y, Liu CG, Zhang ZH, Zhang HS, et al: Downregulation of
miR-204 expression correlates with poor clinical outcome of glioma
patients. Hum Pathol. 63:46–52. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Canu V, Sacconi A, Lorenzon L, Biagioni F,
Lo Sardo F, Diodoro MG, Muti P, Garofalo A, Strano S, D'Errico A,
et al: MiR-204 down-regulation elicited perturbation of a gene
target signature common to human cholangiocarcinoma and gastric
cancer. Oncotarget. 8:29540–29557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Butrym A, Rybka J, Baczynska D, Tukiendorf
A, Kuliczkowski K and Mazur G: Low expression of microRNA-204
(miR-204) is associated with poor clinical outcome of acute myeloid
leukemia (AML) patients. J Exp Clin Cancer Res. 34:682015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Matkar S, Xie G, An C, He X, Kong
X, Liu X and Hua X: BRD4 inhibitor IBET upregulates p27kip/cip
protein stability in neuroendocrine tumor cells. Cancer Biol Ther.
18:229–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shao J, Li S, Palmqvist L, Fogelstrand L,
Wei SY, Busayavalasa K, Liu K and Liu VM: p27(KIP1) and PTEN
cooperate in myeloproliferative neoplasm tumor suppression in mice.
Exp Hematol Oncol. 5:172016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Filippakopoulos P, Qi J, Picaud S, Shen Y,
Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, et
al: Selective inhibition of BET bromodomains. Nature.
468:1067–1073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y,
Li H, Wang L, Wang X and Zhao C: MiR-204 inhibits human NSCLC
metastasis through suppression of NUAK1. Br J Cancer.
111:2316–2327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng J, Wei M, Shi R, Cai C, Liu X, Li T
and Ma W: MiR-204-5p/Six1 feedback loop promotes
epithelial-mesenchymal transition in breast cancer. Tumour Biol.
37:2729–2735. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Yu X and Bai Q: miR-204 inhibits
invasion and epithelial-mesenchymal transition by targeting FOXM1
in esophageal cancer. Int J Clin Exp Pathol. 8:12775–12783.
2015.PubMed/NCBI
|
|
16
|
Gao X, Wu X, Zhang X, Hua W and Zhang Y,
Maimaiti Y, Gao Z and Zhang Y: Inhibition of BRD4 suppresses tumor
growth and enhances iodine uptake in thyroid cancer. Biochem
Biophys Res Commun. 469:679–685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu Y, Zhou J, Ye F, Xiong H, Peng L, Zheng
Z, Xu F, Cui M, Wei C, Wang X, et al: BRD4 inhibitor inhibits
colorectal cancer growth and metastasis. Int J Mol Sci.
16:1928–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
